Skip to main content
. 2024 Feb 1;44(1):01. doi: 10.35946/arcr.v44.1.01

Table 1.

Summary of Preclinical and Clinical Studies Assessing the Effects of Fecal Microbiota Transplant (FMT) on Alcohol-Related Outcomes

Study* Subjects Model Main Finding
Ferrere et al. (2017)23 Mice Signs of ALD lesions after Lieber-DeCarli diet FMT prevented the development of alcohol-induced liver lesions, but the effect depended on the host microbiome.
Wrzosek et al. (2021)30 Mice Signs of ALD after FMT from SAH patients Pectin-FMT beneficially reshaped the GM, in an AhR-dependent manner.
Yu et al. (2020)31 Mice Signs of ALD lesions after Lieber-DeCarli diet with ethanol FMT or LRP6-CRISPR improved GM diversity and composition to ameliorate ALD symptoms.
Yan et al. (2021)32 Mice Signs of ALD lesions after Lieber-DeCarli diet with ethanol TQE supplementation or TQE-FMT alleviated chronic alcohol-induced liver injury and markers of gut barrier dysfunction.
Yan et al. (2021)33 Mice Signs of ALD lesions after Lieber-DeCarli diet with ethanol UA had hepatoprotective effects and suppressed alcohol-induced oxidative stress and intestinal barrier disruption.
Guo et al. (2022)34 Mice Acute ALD signs by ethanol lavage Goji berries restored intestinal epithelial cell integrity and prevented acute liver injury induced by alcohol intake.
Xiao et al. (2018)39 Mice FMT from noncontingent drinking mice Alc-FMT transferred negative affective behaviors following withdrawal, altered brain gene expression, and reduced GM diversity.
Segovia-Rodriguez et al. (2022)40 Rats FMT from ethanol-exposed rats (10 g/kg for 10 days) Alc-FMT increased drinking and reduced locomotor activity, but this was dependent on antibiotics pretreatment.
Ezquer et al. (2022)42 Alcohol-preferring rats Alcohol relapse drinking and LGG treatment LGG modified the GM, reduced alcohol intake, and altered brain protein expression in a model of relapse drinking.
Bajaj et al. (2021)56 Humans Patients with alcohol-associated cirrhosis and AUD FMT reduced alcohol consumption and cravings and increased microbial diversity.
Philips et al. (2022)58 Humans SAH hepatitis patients FMT decreased alcohol relapse rates and increased time to relapse, increased beneficial GM diversity, and lowered rates of infections and hospitalizations with higher survival rates.
Philips et al. (2017)59 Humans Open-label study of patients ineligible for steroid therapy FMT recipients had higher transplant-free survival associated with reduction in pathogenic bacteria.
Sharma et al. (2022)60 Humans Open-lab nonrandomized trial with severe alcohol-associated hepatitis with ACLF FMT significantly reduced 28- and 90-day mortality and inflammatory cytokines.
Bajaj et al. (2017)62 Humans Open-label randomized trial: outpatient men with cirrhosis and recurrent HE received FMT enema Improved cognition along with increased microbial diversity.
Bajaj et al. (2019)65 Humans Randomized, single-blind study: cirrhosis with recurrent HE receiving FMT capsules vs. placebo FMT capsules were safe and improved duodenal mucosal diversity, dysbiosis, and objective measures of encephalopathy.
Philips et al. (2018)68 Humans Comparative study between pentoxifylline, corticosteroid, nutritional therapy, and FMT FMT had highest survival rates at 3-month follow-up by modulating GM composition and function and decreasing inflammatory pathways.
Zhao et al. (2020)38 Humans to mice Cross-species Alc-FMT Human to mouse Alc-FMT increased alcohol preference and negative affective behaviors and altered brain gene expression.
Wolstenholme et al. (2022)41 Humans to mice Cross-species Alc-FMT and treated Alc-FMT Alcohol preference and intake were reduced in patients with AUD after receiving FMT, and this behavior was transmissible to mice; liver, intestine, and brain gene expression was altered in mice.
Leclercq et al. (2020)43 Humans to mice Cross-species Alc-FMT Human-to-mouse Alc-FMT increased depression-like behavior and lowered sociability; brain neurotransmitter and myelin gene expression were altered.

Studies are ordered by citation number within each subject type.

Note: ACLF, acute-on-chronic liver failure; AhR, aryl hydrocarbon receptor; Alc, alcohol; ALD, alcohol-associated liver disease; AUD, alcohol use disorder; CRISPR, clustered regularly interspaced short palindromic repeats; FMT, fecal microbiota transplant; GM, gut microbiota; HE, hepatic encephalopathy; LGG, Lactobacillus rhamnosus Gorbach-Goldin; LRP6, low-density lipoprotein-related protein 6; SAH, severe alcohol-associated hepatitis; TQE, Thymus quinquecostatus Celak extract; UA, ursolic acid.